Study of rheumatoid arthritis in older patients: a cross-sectional study

Abstract Background Rheumatoid Arthritis (RA) in older adults is a chronic inflammatory condition causing severe disability and impacting patients’ physical, psychological, and social health. It lowers productivity in society and puts pressure on healthcare systems. This study aims to explore the di...

Full description

Saved in:
Bibliographic Details
Main Authors: Ramesh Kumar Sah, A. B. Dey, P. Chatterjee, A. Chakrawarty, Uma Kumar, S. N. Dwivedi, C. J. Das
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Geriatrics
Subjects:
Online Access:https://doi.org/10.1186/s12877-025-06242-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849761316973051904
author Ramesh Kumar Sah
A. B. Dey
P. Chatterjee
A. Chakrawarty
Uma Kumar
S. N. Dwivedi
C. J. Das
author_facet Ramesh Kumar Sah
A. B. Dey
P. Chatterjee
A. Chakrawarty
Uma Kumar
S. N. Dwivedi
C. J. Das
author_sort Ramesh Kumar Sah
collection DOAJ
description Abstract Background Rheumatoid Arthritis (RA) in older adults is a chronic inflammatory condition causing severe disability and impacting patients’ physical, psychological, and social health. It lowers productivity in society and puts pressure on healthcare systems. This study aims to explore the different aspects of RA and investigate the diagnostic potential of serum marker 14-3-3η. Method This Cross-sectional study recruited 205 arthritis patients (63 RA and 142 OA) over sixty years old. The participants underwent a thorough clinical evaluation according to the established design. Anti-CCP and serum 14-3-3η levels were measured. Simple logistic regression was performed to identify significant predictors of RA. ROC curve determined optimal cut-off value for 14-3-3η. Results This study reported an average age of 63.67 years with a high female-to-male ratio of 4:1 in the RA cohort, while in the OA cohort, the mean age was 65.5 years with a low female-to-male ratio of 2:1 overall. Symptomatically, RA patients exhibited earlier onset, pronounced early morning stiffness, fever, weight loss, myalgia, and fatigue, all with highly significant p-values (< 0.001). Comorbidities showed higher incidences of anemia, ILD, and osteoporosis in RA patients. Impaired ADL and IADL were noted in 17.5% and 73.2%, respectively. Impaired HMSE and GDS were found in 36.5% and 74.6%, respectively. Logistic regression analysis identified key predictors distinguishing RA from OA, including EMS (OR: 1.09, p < 0.001), fever (OR: 6.68, p < 0.001), weight loss (OR: 6.35, p < 0.001), myalgia (OR: 5.07, p < 0.001), osteoporosis (OR: 2.21, p = 0.013), ACCP levels (OR: 1.28, p < 0.001), and the novel marker 14-3-3η (OR: 2.87, p = 0.047). Using both ACCP and14-3-3η markers, 88.88% of RA patients were positive for at least one marker, enhancing its diagnostic coverage. Elderly onset RA (EORA) patients had a significantly higher age and shorter disease duration compared to those with young onset RA (YORA). The female-to-male ratio in the YORA and EORA group were 6.97:1 and 1.66:1 respectively. PMR-like symptoms were more prevalent in the EORA group (31.25% vs.14.9%). Hypothyroidism was more frequent in the EORA group (31% vs. 17%). Sulfasalazine was more commonly prescribed in both EORA (100%) and YORA (89%) groups. Conclusion This study contributes to a better understanding of distinguishing RA from OA. It also highlights the differences between young and elderly onset RA, and supports the diagnostic potential of the serum marker 14-3-3η.
format Article
id doaj-art-3b07b98cd45c46d3a887c0dbce38816d
institution DOAJ
issn 1471-2318
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series BMC Geriatrics
spelling doaj-art-3b07b98cd45c46d3a887c0dbce38816d2025-08-20T03:06:04ZengBMCBMC Geriatrics1471-23182025-07-0125111210.1186/s12877-025-06242-8Study of rheumatoid arthritis in older patients: a cross-sectional studyRamesh Kumar Sah0A. B. Dey1P. Chatterjee2A. Chakrawarty3Uma Kumar4S. N. Dwivedi5C. J. Das6Max Life Multi Specialty Hospital and Research CenterDepartment of Geriatric Medicine, All India Institute of Medical Sciences (AIIMS)Department of Geriatric Medicine, All India Institute of Medical Sciences (AIIMS)Department of Geriatric Medicine, All India Institute of Medical Sciences (AIIMS)Department of Rheumatology, AIIMSDepartment of Biostatistics, AIIMSDepartment of Radiology, AIIMSAbstract Background Rheumatoid Arthritis (RA) in older adults is a chronic inflammatory condition causing severe disability and impacting patients’ physical, psychological, and social health. It lowers productivity in society and puts pressure on healthcare systems. This study aims to explore the different aspects of RA and investigate the diagnostic potential of serum marker 14-3-3η. Method This Cross-sectional study recruited 205 arthritis patients (63 RA and 142 OA) over sixty years old. The participants underwent a thorough clinical evaluation according to the established design. Anti-CCP and serum 14-3-3η levels were measured. Simple logistic regression was performed to identify significant predictors of RA. ROC curve determined optimal cut-off value for 14-3-3η. Results This study reported an average age of 63.67 years with a high female-to-male ratio of 4:1 in the RA cohort, while in the OA cohort, the mean age was 65.5 years with a low female-to-male ratio of 2:1 overall. Symptomatically, RA patients exhibited earlier onset, pronounced early morning stiffness, fever, weight loss, myalgia, and fatigue, all with highly significant p-values (< 0.001). Comorbidities showed higher incidences of anemia, ILD, and osteoporosis in RA patients. Impaired ADL and IADL were noted in 17.5% and 73.2%, respectively. Impaired HMSE and GDS were found in 36.5% and 74.6%, respectively. Logistic regression analysis identified key predictors distinguishing RA from OA, including EMS (OR: 1.09, p < 0.001), fever (OR: 6.68, p < 0.001), weight loss (OR: 6.35, p < 0.001), myalgia (OR: 5.07, p < 0.001), osteoporosis (OR: 2.21, p = 0.013), ACCP levels (OR: 1.28, p < 0.001), and the novel marker 14-3-3η (OR: 2.87, p = 0.047). Using both ACCP and14-3-3η markers, 88.88% of RA patients were positive for at least one marker, enhancing its diagnostic coverage. Elderly onset RA (EORA) patients had a significantly higher age and shorter disease duration compared to those with young onset RA (YORA). The female-to-male ratio in the YORA and EORA group were 6.97:1 and 1.66:1 respectively. PMR-like symptoms were more prevalent in the EORA group (31.25% vs.14.9%). Hypothyroidism was more frequent in the EORA group (31% vs. 17%). Sulfasalazine was more commonly prescribed in both EORA (100%) and YORA (89%) groups. Conclusion This study contributes to a better understanding of distinguishing RA from OA. It also highlights the differences between young and elderly onset RA, and supports the diagnostic potential of the serum marker 14-3-3η.https://doi.org/10.1186/s12877-025-06242-8Rheumatoid arthritisElderly-onset rheumatoid arthritisSerum 14-3-3η
spellingShingle Ramesh Kumar Sah
A. B. Dey
P. Chatterjee
A. Chakrawarty
Uma Kumar
S. N. Dwivedi
C. J. Das
Study of rheumatoid arthritis in older patients: a cross-sectional study
BMC Geriatrics
Rheumatoid arthritis
Elderly-onset rheumatoid arthritis
Serum 14-3-3η
title Study of rheumatoid arthritis in older patients: a cross-sectional study
title_full Study of rheumatoid arthritis in older patients: a cross-sectional study
title_fullStr Study of rheumatoid arthritis in older patients: a cross-sectional study
title_full_unstemmed Study of rheumatoid arthritis in older patients: a cross-sectional study
title_short Study of rheumatoid arthritis in older patients: a cross-sectional study
title_sort study of rheumatoid arthritis in older patients a cross sectional study
topic Rheumatoid arthritis
Elderly-onset rheumatoid arthritis
Serum 14-3-3η
url https://doi.org/10.1186/s12877-025-06242-8
work_keys_str_mv AT rameshkumarsah studyofrheumatoidarthritisinolderpatientsacrosssectionalstudy
AT abdey studyofrheumatoidarthritisinolderpatientsacrosssectionalstudy
AT pchatterjee studyofrheumatoidarthritisinolderpatientsacrosssectionalstudy
AT achakrawarty studyofrheumatoidarthritisinolderpatientsacrosssectionalstudy
AT umakumar studyofrheumatoidarthritisinolderpatientsacrosssectionalstudy
AT sndwivedi studyofrheumatoidarthritisinolderpatientsacrosssectionalstudy
AT cjdas studyofrheumatoidarthritisinolderpatientsacrosssectionalstudy